Effective gastrointestinal problems are common in the pediatric age group, including pediatric gastrointestinal oncology. He first identified this phenomenon in 1958, when he coined the term "new respiratory syndrome" (RAP), a term for a group of young people suffering from persistent or persistent stomach disease, due to crime that affected daily life, without natural causes. .
This review focuses on diet, medication, cognitive-behavioral and reciprocal therapy. Irritable bowel syndrome (IBS), like gastroenteritis, occurs more often in adults, and most of the medications used in adults are designed to treat this condition.
Drugs to treat pain, anxiety, and seizures have become experts in the treatment of gastrointestinal disorders because they target the local sensory and limbic systems to control mental status, seizures, and neuropathic pain, and anticholinergic effects. Increases autonomy to a certain level of coverage.
Antidepressants such as tricyclic antidepressants (TCAs), serotonin reuptake inhibitors (SSRIs), and monoamine uptake inhibitors can exacerbate the effects of IBS in adults. Antidepressants work by reducing pain sensations, improving cognitive control and rest patterns, and possibly controlling movement. Among all effective gastrointestinal problems, IBS (IBS) is the most talked about and widely recognized. IBS is very common, affecting 10-15% of the US population. Level of significance — 35% to 40% of this IBS reference group is male, and 60% to 65% of this IBS reference group is female.
Fuctional GI Conferences | Gastroenterology Meetings | Gastroenterology Conference | Gastroenterology Congress | Gastroenterology Summit | Gastroenterology Expo | Gastro Events | Gastro Meets | Gastro Summit